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[ 1146-1591 Myocardial Blood Flow and Flow Rourve In 
Chi ld ren  A f te r  Arter ia l  Sw i tch  P rocedure  
C S, Ouvemoy', M. Hauser, C, Meyer, I Mntsunan, K BtJhlmeyer, 
M, Schwa~ler 'DnnsmnotCat(1~r~/og~, UnwePMyotMch~#an, AnnArOo~, MI, 
USA: Departments of Nuclear Mecltcme an# F~ed~atno Card~othorac~c 
Surgery4, Technm_.al UnNetsdy of Munch. Munch, Germany 
~l~(gro~ut~;/: Children born with trsnsposd~on of the groat vessels currently 
undergo en arfenal switch pfoo~Jum in the neonatal I~no¢l, rind are flubse. 
quefltly largely asymptom~tm. Them is a low incidence_ O1 perfuslon dete~ts In 
this P~l~daben. 
Me&~d~ We assessed myocardml b~oad flow [MBF) end my~.ard,al vas. 
Ctl~ar esmtarme (MVR) at rest and duneg maximal hyperemm using N.13 
ammonia PET before and after intravenous adenosine mh~s~on i  8 children 
( 11 ± 2 ym) etatus post artenal sw~ch m the neonatal penod, all ot whom had 
no evide~'e of ~schem,a 0y exercise ECG and stress echocardmgrap~y. MBF 
and CFR values were Compared w~lh 9 healthy young adult volunteers (34 
10 yrs). 
Patasnt~ 074 t: 013 10~ ~: 24 24B ~: 04a 31¢a 339~08 
No=ma~s 0~9 t O0? 133 ~ 20 2z3 = 029 31~7 400 ~ 062 
p v~,tue NS 0 04 NS NS 0 04 
Resu/ts: PET was we, tolerated ~ art ch*kJren. Rasing and hyperem~e 
MBF was nol s~gruhcantb/ ~fferent between subtects and normals, but CFR 
was s~jP~f v,.-antly lower m patterns. No c~l  had a CFR value more than 2.5 SD 
below the average t~r no,mats. A stress-reduced perfu~on detect was noted 
m I portent; ttus pabe,~ lad  Ihe ~west CFR vak~ as well. 
~ :  MyocarJ~al bk~od flow ~s ~thm normal range in children wrth 
surc3ca~ corrected transpo~t~n of the gmal artenes, although CFR m re- 
clucecl when compared with young adu~. PET  may be a useful quantstaWe 
tool to ~or  changes m come, an/flow m pa~ents w~th congenial heart d~s- 
ease. Its ~,in~cat s c3~f~c~nc-e r mains u~proven 
1146-1601 The Medium Tet'm in Arteries Rndings Coronary  
) 
by  In tn lvascu la r  U l t rasound in  In fants  and  
Ch i ld ren  A f te r  Heart  T ransp iantat inn  
MA. Kuh~. K.R. Jutzy, S.D. Frrtzsche, C.E. Cephus~ O.D. Der:-. ,-t~. 
LL  Ba~ley, R.E. Chmnock. R.L Lamen. Lorr~ L~tt~a Ll~,-vet~1y, L~"=a ~nda. 
CAUSA 
Background. Intravascu~r ultrasound (IVUS) has been shown to be a ~m'zs,- 
tP.,e tool m the detection of post-transptam coronan/artery d~sease (PTCAD) 
cn adults. Smiter findings have been seen in mA~al studies wd'h chddren 
Methods: Th~s study compared the medium term findings ot IVUS ~n ct~l- 
dmn who tmderwem heat1 transplant (htx) at > 1 yr of age (gp 1 ) to those who 
undemmnt htx at - 1 yr of age (gp 2). Between 7/96 and 6,~J7, 30 chddren 
(ojp 1: n = 17, gp 2. n = 13) had IVUS gerformed at the time of the annual 
cathetenzat~n. A total of 390 segments were evaluated m 39 vessels (LAD 
25, Cx 4. RCA 10). Mean total area (TA). mean lumen area (LA), maxm~al 
mbmal thickness (MIT). and mbmal index (11) (TA-LA/TA) were cafcutated by 
ptammet~. The degree O! intzmal thK~kenmg was dassdied using the Stanford 
scale, The pabent demographics are shown ~n the tabte below. 
Age al ht~ Age al catn Years s~r'~l~ ht~ 
Gpl 10 ~ 5 y','s 14 ~ 5y'm 4 ± 2y~s 
Gp2 2 * 2mos 8 ± ly~s 8z lyre 
ResultS: Companson of MIT and II are shown in the table below. 
Gp 1 Gp 2 D-value 
MIT (mm) 026 ± 0 14 : 004 0 001 
II (%) 11 ± 7 7 ± 3 004 
Both MIT and II were significantly greater in gp 1 than in gp 2. PTCAD 
based on the Stanford classification (see table to the nght) was more severe 
in gp I compared to gp 2. The number of reiection episodes correlated with the 
MIT in gp 1 (r = 0.56. p = 0.02), but not in gp 2 (r = 0.21, p = 05). The number 
0! reiection episodes did not differ bah'men the h'ro groups. CMV status did 
not correlate in either group. 
Class I 2 3 4 
Gp 1 7 6 3 1 
Gp 2 10 3 0 0 
Conclusions: This study suggests that medium term survivors who had a 
htx at <1 yr of age had less PTCAD detected by WUS when competed to 
medium term survivors who had a htx > 1 yr of age. 
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~ A l lopur lno l  Imprevea  Endothe l l l l  Funct ion  In 
NIDDM, but  Me no  E f f~" t  tl l A~KI-mat¢~ 
Young Non.¢i iabetk:  Cont ro l s  
R Bgller t , A,D, Morfl~ ~, A,D: Slrutt~= t , 'Ut~'et~rty Df~oarfrnent ofCling.at 
Pha~t~,  Nfnev~ P,o~p~al nd I~d~caI Sc~o~, Ou,',d~e, PO~ ~ 
UK~ Un~ve~ffy~rtmentot l~mke, Nrnew~t l~ta lan~l  
Schoot, Dundee, DD! 9SY, UK 
Backgroun~ Them is evidence thai anti.oxidant therapies improve endothe. 
hal function (EF) in diabetic, palient.  ^ ~ lh lne  ox~Jase i~ a key flee red,cat 
enzyme generst~ system and Iherefore allopunnol, a =anthme oxidase m- 
h,brtor may produce a s~milar benef~a! effects on EF 
Methc~: We examined 34 patients (11 patmnts with NIDDM, mean age 
(MA) = 65 years; 12 similar aged corffmls, MA = 59 years and 11 your~ 
healthy volunteers, MA = 25 years) treated w~lh 300 mg of allopunno! (1 
month) in a ranclommed, plaeeOo Corltfolled, double-blind, crees--over study 
EF was assossecl by bilateral forearm venous occlusmn plethyemography 
using endothelhal dependent (acetyl ct~olme) and endothehat independent va- 
soddatalors (sodium nt~opruss~e). 
Resu/~" Forearm Mood flow (FBF) response to acstyl choline showo~ a 
s,geffieant increase w~ allopurmol therapy in the NIDDM subgroup (2.63 vs 
2.16 m~100 mlstmm; allopormol v,s placebo p = 0.01; 95% C! 0.11,0.83) but no 
,mpro~w~ent w~th nrtrop~usside. There was a s~gnfftcant redtJ~O~ in mak:~yl- 
~ad le l '~  (MDA) (0.30 vs 0.34 pMA; altopunnel vs placebo p = 002). There 
was no ~,terence m t-lbA1C, choleslerol or I~ood pressure between the study 
days. There was no stgmficaof d~fference between erlher endathehal depen- 
dS ,  or independent response in e~ther the young or old normal subgroups. 
Th~_e r ~  indicate for the flint t~me [nat the altopunnol improves EF but 
only ,n NIDDM. Allopuenol may decrease tree ra~:al generstion increasing 
nltnc oxide h(oavailab~lrty. 
~ A  Comparative Study of Four Anti-hypertensive 
Agents  on  Endothe l ia l  Funct ion  in Pat ients With 
Coronary  Diaease 
T.J. Anderson 1 . R.W. Overhiser, H. Haber, F Charbenneau ~ 'Foo~dts 
HosprtaL Calgary, Canada; : Royal Victoria Hosprtal, Montreal, Canada 
Back~.,'ouncl- Qumapnl, an ACE rn~or  w~n hlgh affinrty, has been shown to 
tmpreve coronary endothef,al dyshJnctmn in patlents with CAD. The effectwve- 
ness of different vasoact~ve agents to fmprove human endothehal function ~s 
unknown. In t l~ BANFF stucty, we used I~gh resolution ultrasound to ~ r e  
tr~e chromc effects of four arm-hypertenswes on brachial artery flow-mediated 
vasodllatTon (FMD) m patmnts wTth documented CAD 
Method's: Patients were enrolled in a pa~al-bleck, cross-over des=gn tnal, 
and randomized m one of four different, open label drug sequences. The core 
ultrasound lab and data analys~s center were masked to treatment. F"MD and 
NTG-mducod ddatton were evaluated before and after 8 weeks of each study 
drug, Two week washout was imposed between treatments. 
ResuRs: CAD patients had s~jmfpcanfty m'~paired FMD (6.2 ± 0.6%, n = 80) 
compared to normals (10.9 ± 08%, N = 40, p ~ 0.05). Absolute changes m 
FMD from baseline am shown below. 
Drug N 3FMD (Mean t SE) p vahm 
Oulnapn120 mg 56 1 8 "-. 1 0% - 0 02 
Enalapnl Omg 55 02  "- 08% 084 
Losartart 50 mg 38 08 *.- 1 1% 0 57 
Amt(~l=plrte 5 mg 45 0 3 ~ 0 9". 0 97 
No szgn!hcanr d~ffefe~ces ,n NTG.~nduced d.'~t,on w~m observed 
Conclusron: Only qumapnl was associated with significant ~mprovement 
,n flow mediated dilation. ACE mh=bRors may differ =n the,r ablhty to rmprove 
vascular endothelial function. 
~ Adenosine and Nitrates Interaction at Coronary 
Macro- and  Mic roc i rcu la tory  Level in Pat ients  
With Syndrome X 
C. Palombo. M Koz~,kov~. G. Biga[li, M eel Tecta CNR Clinical Phystol~ 
Inshtute and Chair of Pharmacology.. Unrversrly of P~sa, /tat}, 
Background: an endothelial dysfunction is reported in Syndrome X (SX). In 
328A ,IAC(" Fcbru.'~ry 199X 
experimental models, nitric oxide (NO) donors am orgsnic nitrates counteract 
the impoirmont of adenosine (ADO) induced vo~odllototlon rosulllng from NO 
synthesis inhibition, 
Aim of the study was to evaluate the effects of oxogonou~ nitrates on the 
vnsodilator corom'lry rssponso to ADO in 28 patients (21 mNos, ? females; 
21 normoton.stvos, 7hypertensives) with cl~ost pale end nnglographlcally nor- 
mnl corenan/ortnrlos, 14 with negative Nod 14 with posltlvo ECG on effort 
(Control~ end SX, m~pocttvoly), 
Method~: under continuous BP monitoring, diameter of Loll Main (LMD) 
nnd coronnn/flow velocity (CFV) from LAD aden/were meastlrOd by TEE- 
Doppler in basel condition nnd Miter l,v, ADO infuslon (700 t,g/Kg in 5 min) 
mp~ntod twice, before nnd niter t,v. isoaorbldo dinitrnte (I~DN, 2 rag/?, mtn), 
Resl#ts" Control~ and 9X were comparnble for ego, gender, BP, plasma 
glucose ~nd Itpids, LMD wos ~igntlicantly Increased neler ADO (,L3 I 1,0 vs 
4,0 ~ 0,g ram, p - 0,01), snd lurthor alter fSDN (4,5 t 0B ram; p .  0,01 vs, 
basrll and ADO), with no difference between Controls Nod ~X, MCR was not 
significantly affected by ISDN In Controls (ADO: 1,00 t 0,09, ADO *, ISDN 
t,1 4- 0,0g mmHg/cm't~oc t), while In ~X IIl0 MCR wfluo attar ADO .0, ISDN 
was significantly lower Ilion niter ADO alone (ADO 1,23 t 0,1, ADO + ISDN 
0,g6 t 0,1 mmHg/cm'soc ~, p, 0,01), 
Conclos/on~: ADO and ISDN show additive vasodtlotlng oIIocts on opt, 
cotdlsl coronory anenos in Controls and SX; however, ISDN In ~X seems 
to increase the response el coronary mtcrocllCtll.rdlOn to ADC), prebohly by 
mdtqclng an addltlonol coronory ~o~lslanca un~ensltlvn to ADO aloes The,so 
findings ~re in keep,~g with the hypolhosi~ ot on ondoff~el~al dystunchon cotqn, 
teracted by nxegonou,~ NO,donom 
[~KS~ 1I . ,p . l , .d  A. ,Hnons Iod.csd Vaaodllatlan in 
Pstlants With Endoth~l la l  Dys funct ion  
T, ~himadn, Y, IshlbnshL T ~akorlo, ~, InDue, H, Yo~hitomi, Y. Ishinaga, 
K, ~nno, Y, MurNkaml, Shtmnnn M~cal Una,~r~g}, Izumo CgB dn/~ln 
E~,Iokgr~¢tn~; We tested the hypolno~t~ that va',tOrtilNton/effect el ype III I}hOs- 
phodiostetNSe Inhibition with nmrlnono (Amr) might be impaired ~n SubleCts 
wlth endothelial dysfunction 
MothOd,q: Foroalm blood flow (FBF) measurements rttalng tnlraadenal 
inluslOO el ncotylcholmn (Acl~), Amr nnd nltroglyconn (I NL~) were podomod 
using plothysmogrnphy tn t0 pohontS with heart INduro and ago roached 10 
control subloCts wdhout aiflaoiC w%~cul~l d soaso bolero nnd allot ndnc oxide 
syntho,~e blocking with N~'-monBmelhybL-anlinme (LNMMA, .100 ~, reel) 
Fle,~ults: The increment of FBF ~n response to Ach and Amr wore do- 
pressed in patients with I~eafl lnduro eompnirod In conh'ol sobiocts In contrast. 
the effect of TNG on FBF was not different between two gronps L-NMMA stg- 
nllicantly decreased an inc~emont o1 FBF m response to Amr in dose el less 
than 100 ~,glmm, but did no1 alter m dose of 100 ~,g;min and mine (serum 
conoenllatlon 1 fig/tel) 
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Conclusion: Amrinono has vasodilnton/effect, in pod, through nitnc oxide 
synthnso, nnd the effect Is Impaired in subjects with endothelial dysfunction. 
• Effests of L- and D.Arglnlne on the Basal Tone of 
Diseased Coronary Arteries and Their Responses 
to Substsnce P 
C, Tontolouri~, D, Totlsotllls, T, CrNko, G, Kntslmaglls, A Androulakis, 
G.J, Davies, P. TOUtOUZNS, Ct~rdtology Units, Hammersmilh Hospgal London, 
UK; Atlten~ UnivePaify Medlc,.tl School, Greece 
B~lckgroltnd: Administration ot L-mgmme, .'1 substrata in the predict!on o! 
andolhelitlm.derived nltli{; oxide may sfimuloted the release of n!lv!e o~Ide, 
This shldy a~sessnd the effects of substance P admmtstrNIion alone end !n 
combination with L. and Do nrgln!ne in patle~nts with normal ang!ogrNms end 
in patients with antenna/aden/disease, 
Metttod~: Inl[~cotonary inf*,lsions of nemlal maline, the receptor mediated 
nltnc oxidd stlmtdont, substance P (5 6 and 27.8 gruel!ram) before and offer L, 
Or D.~rglnlno (50 and |50 omolhn!nt and uit!~3lycelin 1250 mcg boll.m) were 
administe!ed in 17 patients with coronary adery disease and stable angina, 
and in 6 potlents with norma! anglograms The d~ameter el anglogtaphtcalty 
OOIOI01 pro~inlal and dlslNl segments (SI nnd coronary stonoses were men. 
surod by computerized quantitative an,.liOglaphy 
Ft~sltlts L,al'glnloe administration wits associated with slgnll,~,tnt dddtlon 
hem brlsohno el pTo~lmal S el both "nm'mal" (104 ; 34%,, p . 0 05) and 
diseased (el 5 i 1 5%, P - 00t )  ade.os and ot d~stal (6 7 t I 3%, p.  OO1) S 
el dlseNSOd arlenes No s~gnlhcant changes wore associated with D-algmlno 
ndmlnlshatlon (proximal S OO t 1 1%,, dlsta! S: 0.8 r 0 7%) The n~lgn0udo 
el dilation ot diseased col~.nNl'tes, was groate~ (p. 005) afro! L-argmme and 
substance P infusion (proximal S: 12.7 t 1 8%, distal S: 21.0 :; 2.8%,), than 
alter saline and substance P Infusion (proximal S: 7 1 "~ 1.5°o. distal S: 14 
I 25), or O-nrg~nino nnd substance P infusion (proximal S: 7.4 ; 1 5%. d~stal 
S 147 i 27%) 
Cenclustons D~seased and "normal" coronary artenes dilated in response 
to substance P and In response to L,argmmo but were unaffected by D-mg~- 
rune infusion A sigmhcant proporbon of the response to nltroglyconn coutd be 
obtained by L-argmtno administration. The results are consistent ~,~ith sttmu- 
leben el basal nitric oxide synthase activity in atheromatous coronary adertes 
by L-arg~mno The lack ot potonBabon by L-argmme el the vaseddator re- 
sponse to substance P suggests that this response ~s independent of n~mc 
oxide synthaso substrato avadabildy. 
,~-2-2~1114./._5~ Dif ferent ia l  E f fects  of  Int ravenous Endotheiin-, on 
Renal, Pulmonary and Systemic Hemodynamics 
in Healthy Men 
M G $1 John Sutton, M.I Freed, K Thompson T Plappert. O K Jorkasky 
Un~versg), ot P~nnsyh'anra Medzcal Cents: dad Smith Khne B~ct~)m 
P~lrmaceut~cals, PhdaC/etph~d. PA. USA 
Endothehn.t (ET-B ~s a potent vasoconstrictor which ts behoved to play a 
role in the pathogenes~s of a number ot cardiovascular d~seases ~n man 
To investigate the impact on different organ vasculature we prOspectriely 
assessed the effects of a dose range of ET-t infusuons (O0. 0 5, 1 O. 2 0, 
and 2 5 ng/kg~mm) on pulmonary, renal and systemic blood flows measured 
simtdtaneously at basehne, and at one and 3 hours, m a placebo-controlted 
crossovur trial m 8 healthy men. 
Meth~x~s Pulmonary (PBF) and systemic blood t:ows (SBF) were quanta 
toted by Doppler echo as the product of the blood flow velocdy/hme integrals 
and the cross-sectional aruas of the pulmonar~ artery and the left ventncular 
outflow tract obtained from thmr respective diameters LV and RV size and 
hJnction weze assessed by 2D echo and by systohc hme intervals as the rat~o 
of pre-eiechon period (PEP)/Elechon ttme (El T) Etlective renal plasma flow 
(ERPF) was estimaled as the cleauance of pare-amino hnppunc actd. 
~esults: ET-1 caus~.d a dose-dependent redoctzen in mean ERPF. ET-I 
infusion el Z.5 ng/kg, mi:'~ r£:ducdd mean ERPF  by 27 c ~ from 0.59 ~ 003 L/ram 
at baseline to 0.48 ~ 0.03 L/rain (p. 0.05) compared to a 0.1"o change wdh 
placebo. Systohe blood pressure increased by a mean of 9 mm H9 but head 
rate did not change at ET-1 infusion of 2.5 ng/kg/mm. By contrast. ET-1 at 
doses up to 2.5 ng!kg/min did not result in any signiltcant change in LV size, 
stroke volume (65 .~ 11 vs 62 ~ 11 ml), % LV shortening (51 *, 6 vs 49 .. 5), 
PEP/LVEiT (0.40 ~ 0.02 vs 0.41 ~, 0.10), PBF (461 * 0.82 vs 4 98 i 1.13 
L/rain) el in HV PEP/RVEIT (0.36 ~ 0.03 vs 0.36 ~. 0.06) compared to placebo. 
Conclusion: Low doses of exogenous ET-1 has very dtffemnt effects on 
the pulmonary, systemic and renal vascular beds. The renal vasculature is 
e~qubsdely sensitive to the vasoconstrictor action of ET-1, but ET-1 has little 
effect on LV or RV size and function or on modulating systemic or pulmonary 
bided flows in healthy men. 
